HIGHLIGHTS
- who: WNK and colleagues from the Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, United States have published the paper: WNK1 in Malignant Behaviors: A Potential Target for Cancer?, in the Journal: (JOURNAL) of 22/06/2022
- what: We briefly highlight four points that may be considered in future analyses of the actions of WNK1 and other WNK family members in cancers.
- how: The authors showed that inhibition of WNK1 reduces tumor volume and dispersion of metastatic cells in a mouse xenograft model of metastatic breast cancer in part via a network . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.